The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
ImmunoGen, Inc(NASDAQ:IMGN) 
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. Its product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha, which is in Phase III clinical trial for the treatment of platinum-resistant ov...
Website: http://www.immunogen.com
Founded: 1981
Full Time Employees: 75
Sector: Healthcare
Industry: Biotechnology
ImmunoGen Number of Twitter Followers
ImmunoGen Days Payable Outstanding ttm (DPO)
ImmunoGen Days Receivable Outstanding ttm (DSO)
ImmunoGen Days Inventory Outstanding ttm (DIO)
ImmunoGen Op Cashflow Per Share ttm
ImmunoGen Free Cashflow Per Share ttm
ImmunoGen Cash Per Share ttm
ImmunoGen P/S ratio ttm
ImmunoGen (GAAP) P/E ratio ttm
ImmunoGen P/B ratio ttm
No extra charts and metrics for this ticker.